>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
术后应用爱迪注射液对食管癌红细胞免疫影响的临床研究
作者:陈德轩 潘立群 
单位:南京中医药大学,外科学教研室,江苏,南京,210029
关键词:食管癌 红细胞免疫 爱迪注射液 
分类号:R735.1, R730.3
出版年·卷·期(页码):2004·23·第二期(117-119)
摘要:

目的:研究爱迪注射液对食管癌患者术后红细胞免疫功能的影响.方法:术后早期给药,应用郭峰法检测患者围手术期红细胞免疫功能.结果:食管癌患者术前红细胞C3b受体花环率(RBC-C3bRR)、红细胞粘附肿瘤花环率(TRR)明显降低,免疫复合物花环率(RBC-ICRR)升高,与正常相比有高度显著差异(P<0.01);实验组术后7 d与对照组术后14 d比较无显著差异(P>0.05);实验组术后14 d与正常比较无显著差异(P>0.05),接近正常水平,与对照组术后14 d比较差异显著(P<0.05).结论:食管癌患者红细胞C3b受体(CR1)活性下降,粘附肿瘤细胞能力下降,红细胞免疫功能受抑制;爱迪注射液对食管癌患者术后红细胞免疫功能影响较大,实验组术后7 d水平与对照组术后14 d水平相当,而术后14 d水平与正常水平相当,表明爱迪注射液可促进癌症患者红细胞免疫功能较快恢复.

Objective  To study the changes of RBC immunity of esophageal carcinoma(EC) patients by application of Aidi injection after operation for 7 days and interpret the mechanism.Method  Aidi was postoperatively injected to EC patients,the perioperative RBC immunity was detected by Guofeng’s methods.Results  The rates of RBC?C  3bR?TR in esophageal cancer patients were much lower than that of controls and the rates of RBC?ICR was significantly higher than that of controls(  P  <0.01).The rates of RBC?C  3bR?TR detected after removal of the carcinoma were significantly higher than that of patients before operation,but still lower than that of controls,the rate of RBC?ICR detected after removing the carcinoma was significantly lower than that of patients before operation(  P  <  0.01  ),but still higher than that of controls(  P  <  0.01  ).The same changes also happened in experiment group,but much fast than the controls.7 days after operation,the level of red cell immune of experiment group were similar to normal objects (  P  >0.05)and better than the controls.14 days after operation,there was no significantly difference between experiment and control group (  P  >0.01).Conclusion  The red  cell immunity in EC patients was suppressed,injury from operation and anaesthesia makes further suppression.Aidi injection can kill tumour cells and promote the red  cell immunity,the monitoring of these parameters is of significance for the study of therapeutic efficacy and prognosis judgement.

参考文献:

[1] 郭峰, 黄盛东. 天花粉制剂对肿瘤患者红细胞免疫促进作用的体外实验研究, 1991(z1)
[2] 郭峰, 黄盛东, 赫丽. 红细胞在肿瘤免疫中的作用, 1995(3)
[3] Siegel I, LIU T L, GIEICHER N. The red-cell immune system, 1981(2)
[4] Forslid J, HED J, STENDAHL O. Erythrocyte enhancement of C3b-mediated phagocytosis in human neutrophils in vitro:A combined effect of the erythrocyte complement receptor CR1 and erythrocyte scavengers to reactive oxygen metabolites, 1985(1)
[5] 徐瑛, 郭峰, 叶天星. 红细胞增强中性粒细胞吞噬作用及红细胞过氧化物歧化酶的临床意义, 1990(6)
[6] Kalechman Y, HERMAN S, GAFTER U. Enhancing effects of autologous erythrocytes on human or mouse cytokine secretion and IL-2 expression. 1993. doi:10.1006/cimm.1993.1095
[7] Niehans G A, CHERWITZ D L, STALEY N A. Human carcinomas variably express the complement inhibitory proteins CD46 ( Membrane CD55 ( Decay accelerating factor) and CD59 (Protecting), 1996(1)  

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 417162 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364